Physician

Sajid Ali Khan, M.D.

According to 2025 Medicare claims, Sajid Khan, M.D. (NPI: 1033186002) practices physical medicine and rehabilitation in the Binghamton, NY market, with the plurality of this provider's patient population coming from Broome, NY. This provider's primary affiliated billing organization is UNITED MEDICAL ASSOCIATES PC (NPI: 1013972801; TIN: 161395906) and primary practice location at 13790-2120.

Khan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 156 traditional Medicare patients, billed 8,502 HCPCS/CPT codes, and received $105,557 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 3,556 prescription claims across 396 beneficiaries totaling $161,911 in drug costs, led by Oxycontin (Oxycodone Hcl). 2017 DME data shows 13 claims. Open Payments data shows 12 records totaling $201. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $227,352 and ending at $105,557. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $160,104 and ending at $161,911. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	419	4,544	$227,352
2016	250	2,766	$142,747
2017	230	2,040	$90,622
2018	263	6,736	$123,014
2019	260	8,059	$138,736
2020	197	4,936	$92,523
2021	187	8,307	$126,290
2022	185	8,056	$112,215
2023	169	6,814	$98,501
2024	156	8,502	$105,557

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	363	1,734	$160,104
2016	269	1,830	$175,604
2017	252	1,638	$145,917
2018	288	1,819	$164,759
2019	301	1,954	$163,659
2020	276	1,715	$102,884
2021	331	2,528	$147,145
2022	353	3,602	$249,474
2023	373	2,866	$192,969
2024	396	3,556	$161,911

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	13	$320
2017	N/R	13	$103
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	116	312	$87
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	99	189	$63
20553	Injection of trigger points, 3 or more muscles	41	72	$41
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	118	356	$13
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	58	147	$1

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Oxycontin	Oxycodone Hcl	39	1,144	$30,399
Nucynta	Tapentadol Hcl	15	424	$14,699
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	488	12,824	$10,798
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	434	11,787	$8,398
Lyrica	Pregabalin	13	390	$7,604

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	12	$201	SK Life Science, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Sajid Ali Khan, M.D.?

Tedicare shows public-source Medicare data for Sajid Ali Khan, M.D. (NPI 1033186002), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sajid Ali Khan, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Sajid Ali Khan, M.D.?

Sajid Ali Khan, M.D. is linked to UNITED MEDICAL ASSOCIATES PC (billing NPI 1013972801) in the available physician profile data.

Does Sajid Ali Khan, M.D. have Open Payments data?

Sajid Ali Khan, M.D. has 12 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.